Immunotargets And Therapy

SCIE

国际简称：IMMUNOTARGETS THER 参考译名：免疫靶点和治疗

主要研究方向：IMMUNOLOGY 非预警期刊审稿周期：16 Weeks

《免疫靶点和治疗》(Immunotargets And Therapy)是一本由Dove Medical Press出版的以IMMUNOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
90 年发文量
4.1 IF影响因子
未开放 是否OA
1 issue/year 出版周期
English 出版语言

Immunotargets and Therapy is an academic journal dedicated to the fields of immunology and therapy, aiming to provide a platform for researchers, clinicians, and professionals in related fields to exchange the latest research results, treatment strategies, and clinical applications in immunology. This journal focuses on the role of the immune system in diseases, the development and application of immunotherapy, and the research of immunomodulatory drugs.

The journal covers a wide range of topics, including but not limited to immune regulation mechanism, vaccine development, autoimmune diseases, tumor immunotherapy, infectious diseases immunity, and the relationship between the immune system and chronic diseases. The magazine provides readers with in-depth industry insights and practical guidance by publishing original research papers, review articles, clinical trial reports, and case studies. The journal emphasizes the importance of immunotherapy in modern medicine, encourages interdisciplinary research methods, and promotes the integration of immunology with other disciplines such as molecular biology, genetics, pharmacology, and clinical medicine. Through these studies, the journal helps readers better understand how the immune system is used to treat various diseases, including cancer, autoimmune diseases and infectious diseases.

[ 查看全部 ]

投稿咨询加急咨询

Immunotargets And Therapy期刊信息

ISSN：2253-1556
出版语言：English
是否OA：未开放
出版地区：United Kingdom
是否预警：否
出版商：Dove Medical Press
出版周期：1 issue/year
开源占比：0.9672
Gold OA文章占比：99.37%
OA被引用占比：1
出版国人文章占比：0.04
出版撤稿占比：
研究类文章占比：68.89%

Immunotargets And Therapy CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

3.7

1.11

1.031

学科类别	分区	排名	百分位
大类：Medicine 小类：Immunology and Allergy	Q3	145 / 234	38%
大类：Medicine 小类：Immunology	Q3	155 / 243	36%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Immunotargets And Therapy中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	IMMUNOLOGY 免疫学	3区

Immunotargets And Therapy JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：IMMUNOLOGY	ESCI	Q2	70 / 183	62
学科：IMMUNOLOGY	ESCI	Q3	97 / 183	47.27

Immunotargets And Therapy历年数据统计

影响因子

中科院分区

Immunotargets And Therapy中国学者发文选摘

1、Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Managemen
Author: Freiha, Joumana; Min, Young Gi; Osman, Chinar; Rajabally, Yusuf A

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S390161
2、Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-(3 Signaling-Mediated Anti-PD-L1 Response in Bladder Cance
Author: Liang, Hai-Qi; Li, Yu-Jian; Yu, Jia-Yin; Mo, Qi-Zhou; Wei, Qiu-Ju; Liang, Yu-Qi; Wei, Fa-Ye; Zhang, Xiao-Ping; Zhao, Jia-Wen; He, Yu-Xian; Feng, Xin-Dong; Yin, Bin-Tong; Liang, Xin-Wen; Nong, Ren-Jun; Wang, Yao-Yu; Qin, Min; Cheng, Ji-Wen

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S583577
3、New Insights on IgA Nephropathy from the Perspective of Active Lesions and Systemic Inflammatory Response
Author: Yang, Yang; Xu, Gaosi

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S585437
4、UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR
Author: Xie, Yuming; Hu, Yue; Huang, Junke; Liu, Juan; Zhang, Qing

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S571037
5、Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategie
Author: Cao, Zixuan; Tong, Shurong; Wang, Zihan; Ji, Chenhui; Zhang, Chaoyong; Dai, Xingliang; Wu, Bingshan

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S581012
6、NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosi
Author: Kong, Weihao; Hu, Ying; Zhang, Kangjie; Zhu, Zhipeng; Zou, Yajun; Teng, Long; Wang, Xingyu; Zhang, Jianlin

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S541852
7、Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical Translatio
Author: Gao, Yan; Dai, Rui; Kong, Chang; Niu, Zejun; Yuan, Li; Liu, Xiaojie

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S580700
8、A Retrospective Study on the Clinical Characteristics and Management of Immune-Related Adverse Events in Gynecologic Cancer Patients Treated with Immune Checkpoint Inhibitor
Author: Xia, Yu; Gao, Song; Wei, Qianxue; Gu, Wen; Li, Xiuqin; Qu, Hui

Journal: IMMUNOTARGETS AND THERAPY. 2026; Vol. 15, Issue , pp. -. DOI: 10.2147/ITT.S566542